Monthly Prescribing Reference

Uceris Rectal Foam for Distal Ulcerative Colitis Granted Tentative Approval

FDA Accepts NDA for Budesonide Rectal Foam Salix announced that the Food and Drug Administration (FDA) has granted tentative approval for Uceris (budesonide) rectal foam for the induction of remission ...
Medscape

Topical Agents for Idiopathic Distal Colitis and Proctitis

Rectally administered topical agents have demonstrated efficacy in the maintenance of distal colitis (DC) and proctitis and as they are rarely associated with significant blood drug levels, side ...
Business Wire

UCERIS® (budesonide) 2mg Rectal Foam for the Induction of Remission of Mild-to-Moderate Distal Ulcerative Colitis Granted Tentative Approval by FDA

“ Distal ulcerative colitis can be challenging for patients to live with and gastroenterologists to treat. Our goal is to put the disease into remission so that patients can get on with their lives,” ...
Yahoo Finance

Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Business Wire

First Sulfite-Free Formulation for The Treatment of Active Mild to Moderate Distal Ulcerative Colitis - Now Available

ATLANTA--(BUSINESS WIRE)--sfRowasa™ (mesalamine) Rectal Suspension 4g/60mL –Sulfite-Free Formulation, is the first sulfite-free rectal suspension available for Ulcerative colitis (UC). According to a ...
Monthly Prescribing Reference

Final Approval of Uceris Rectal Foam for Ulcerative Colitis Granted by FDA

Final Approval of Uceris Rectal Foam for Ulcerative Colitis Granted by FDA The Food and Drug Administration (FDA) has granted final approval for Uceris (budesonide; Salix) 2mg rectal foam for the ...
Nasdaq

Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults

LAVAL, QC / ACCESSWIRE / May 23, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced additional Canadian public drug plan listings for Pr ...
Yahoo Finance

New Bausch Health Treatment PrUCERIS(R) (budesonide) Aerosol Foam Now Available Across Canada to Treat Mild to Moderate Distal Ulcerative Colitis in Adults

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Everyday Health

7 Embarrassing Ulcerative Colitis Symptoms — Solved

Use these doctor-approved tips to quell nausea, stomach cramping, gas, and more. For any given symptom, it’s essential to know if it’s related to underlying inflammation or if it’s happening despite ...
Medscape

Topical Agents for Idiopathic Distal Colitis and Proctitis

Once remission has been achieved, however, there is no evidence that steroid enemas will maintain the remission. [27] Thus with the risk of cumulative systemic absorption of topically administered ...
PharmiWeb

Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to ...

UCERIS is now available for patients through the public drug plans of five Canadian provinces: Ontario, Quebec, Saskatchewan, New Brunswick and Nova Scotia. These first public drug plan listings for ...